155 related articles for article (PubMed ID: 31210313)
1. Knockdown of long noncoding RNA SNHG7 inhibits the proliferation and promotes apoptosis of thyroid cancer cells by downregulating BDNF.
Wang YH; Huo BL; Li C; Ma G; Cao W
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4815-4821. PubMed ID: 31210313
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SNHG7 promotes the proliferation and inhibits apoptosis of gastric cancer cells by repressing the P15 and P16 expression.
Wang MW; Liu J; Liu Q; Xu QH; Li TF; Jin S; Xia TS
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4613-4622. PubMed ID: 29131253
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG7 promotes the proliferation and inhibits apoptosis of renal cell cancer cells by downregulating CDKN1A.
Dong JS; Wu B; Jiang B
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10241-10247. PubMed ID: 31841178
[TBL] [Abstract][Full Text] [Related]
4. LncRNA-SNHG7 regulates proliferation, apoptosis and invasion of bladder cancer cells assurance guidelines.
Zhong X; Long Z; Wu S; Xiao M; Hu W
J BUON; 2018; 23(3):776-781. PubMed ID: 30003751
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG7 participates in osteosarcoma progression by down-regulating p53 via binding to DNMT1.
Zhang GD; Gai PZ; Liao GY; Li Y
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3602-3610. PubMed ID: 31114984
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of long noncoding RNA DLX6-AS1 inhibits migration and invasion of thyroid cancer cells by upregulating UPF1.
Zhong ZB; Wu YJ; Luo JN; Hu XN; Yuan ZN; Li G; Wang YW; Yao GD; Ge XF
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10867-10873. PubMed ID: 31858555
[TBL] [Abstract][Full Text] [Related]
7. The function of SNHG7/miR-449a/ACSL1 axis in thyroid cancer.
Guo L; Lu J; Gao J; Li M; Wang H; Zhan X
J Cell Biochem; 2020 Oct; 121(10):4034-4042. PubMed ID: 31961004
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of lncRNA SNHG7 inhibits proliferation and invasion of nasopharyngeal carcinoma cells through repressing ROCK1.
Wang L; Xu T; Cui X; Han M; Zhou LH; Wei ZX; Xu ZJ; Jiang Y
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6186-6193. PubMed ID: 31364118
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA AFAP1-AS1 promoted osteosarcoma proliferation and invasion via upregulating BDNF.
Zhao BM; Cheng FH; Cai L
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2744-2749. PubMed ID: 31002124
[TBL] [Abstract][Full Text] [Related]
10. SNHG7 mediates cisplatin-resistance in non-small cell lung cancer by activating PI3K/AKT pathway.
Chen K; Abuduwufuer A; Zhang H; Luo L; Suotesiyali M; Zou Y
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6935-6943. PubMed ID: 31486493
[TBL] [Abstract][Full Text] [Related]
11. Roles of the SNHG7/microRNA‑9‑5p/DPP4 ceRNA network in the growth and
Chen W; Yu J; Xie R; Zhou T; Xiong C; Zhang S; Zhong M
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649840
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG7 promotes the proliferation of esophageal cancer cells and inhibits its apoptosis.
Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2653-2661. PubMed ID: 29771415
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
Luo X; Song Y; Tang L; Sun DH; Ji DG
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
[TBL] [Abstract][Full Text] [Related]
14. miR-146a interacting with lncRNA EPB41L4A-AS1 and lncRNA SNHG7 inhibits proliferation of bone marrow-derived mesenchymal stem cells.
Cui P; Zhao X; Liu J; Chen X; Gao Y; Tao K; Wang C; Zhang X
J Cell Physiol; 2020 Apr; 235(4):3292-3308. PubMed ID: 31612476
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA SNHG7 promotes migration and invasion of melanoma via upregulating SOX4.
Zhang C; Zhu B; Li XB; Cao YQ; Yang JC; Li X; Liu YX; Wang YB
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4828-4834. PubMed ID: 31210315
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA SNHG7 represses the expression of RBM5 to strengthen metastasis of hepatocellular carcinoma.
Sun BZ; Ji DG; Feng ZX; Wang Y
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5699-5704. PubMed ID: 31298322
[TBL] [Abstract][Full Text] [Related]
17. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of long non‑coding RNA CCAT2 suppresses the progression of thyroid cancer by inhibiting the Wnt/β‑catenin pathway.
Xin S; Ye X
Int J Mol Med; 2020 Dec; 46(6):2047-2056. PubMed ID: 33125134
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA (lncRNA) small nucleolar RNA host gene 7 (SNHG7) promotes breast cancer progression by sponging miRNA-381.
Gao YT; Zhou YC
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6588-6595. PubMed ID: 31378900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
